7.00
-0.10
(-1.41%)
As of 3:34:33 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | -0.29 | 0.62 |
| Low Estimate | 0 | 0 | -0.3 | -0.35 |
| High Estimate | 0 | 0 | -0.28 | 1.6 |
| Year Ago EPS | -- | -- | -0.44 | -0.29 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 138M |
| Low Estimate | -- | -- | -- | 138M |
| High Estimate | -- | -- | -- | 138M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.29 | 0.62 |
| 7 Days Ago | 0 | 0 | 0.72 | -0.41 |
| 30 Days Ago | 0 | 0 | 0.72 | -0.41 |
| 60 Days Ago | 0 | 0 | 0.72 | -0.41 |
| 90 Days Ago | 0 | 0 | 0.72 | -0.41 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INIT.ST | -- | -- | 34.09% | 315.52% |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Related Tickers
ZICC.ST Ziccum AB (publ)
0.2500
0.00%
KTTAW Pasithea Therapeutics Corp.
0.0251
-32.16%
NLSPW NLS Pharmaceutics AG
0.0170
+30.57%
DRMAW Dermata Therapeutics, Inc.
0.0297
0.00%
ACE.ST Ascelia Pharma AB (publ)
2.9150
+1.92%
SANION.ST Saniona AB (publ)
7.80
-0.76%
GMAB.CO Genmab A/S
1,424.50
+1.03%
MNMD Mind Medicine (MindMed) Inc.
7.16
+0.42%
CRSP CRISPR Therapeutics AG
42.34
+0.70%
VKTX Viking Therapeutics, Inc.
34.38
+2.03%